Pharmacokinetics Study of Oral 2-Deoxy-D-Glucose (2DG) in Subjects With a Confirmed Diagnosis of Epilepsy

NCT05605301 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Epilepsy; Seizure

Interventions

DRUG: Oral 2-Deoxy-D-Glucose (2DG)

Sponsor

University of Virginia

Collaborators

[object Object]
[object Object]